Literature DB >> 8331739

Differential activation of human immunodeficiency virus type 1 and 2 transcription by specific T-cell activation signals.

M C Hannibal1, D M Markovitz, N Clark, G J Nabel.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) and HIV-2 enhancers are induced differentially by physiologic T-cell activation signals. In contrast to that of HIV-1, HIV-2 transcription was quite responsive to stimulation of T cells by antigen presentation but weakly induced by tumor necrosis factor alpha. Like tumor necrosis factor alpha, expression of cloned NF-kappa B subunits strongly activated the HIV-1, but not the HIV-2, enhancer. The differences in response to these physiologic T-cell activation pathways may contribute to the differences in persistence of HIV-1 and HIV-2 infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8331739      PMCID: PMC237893     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Activation of the human immunodeficiency virus type 1 enhancer is not dependent on NFAT-1.

Authors:  D M Markovitz; M C Hannibal; M J Smith; R Cossman; G J Nabel
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

Review 2.  T cell antigen receptor activation pathways: the tyrosine kinase connection.

Authors:  R D Klausner; L E Samelson
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

Review 3.  Biologic features of HIV-2. An update.

Authors:  P J Kanki
Journal:  AIDS Clin Rev       Date:  1991

4.  Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65.

Authors:  R M Schmid; N D Perkins; C S Duckett; P C Andrews; G J Nabel
Journal:  Nature       Date:  1991-08-22       Impact factor: 49.962

Review 5.  The biochemistry of AIDS.

Authors:  Y N Vaishnav; F Wong-Staal
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

6.  Antigen presentation by Ia+ B cell hybridomas to H-2-restricted T cell hybridomas.

Authors:  J Kappler; J White; D Wegmann; E Mustain; P Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

Review 7.  Immunopathogenesis of HIV infection.

Authors:  Z F Rosenberg; A S Fauci
Journal:  FASEB J       Date:  1991-07       Impact factor: 5.191

Review 8.  Genetic regulation of human immunodeficiency virus.

Authors:  K Steffy; F Wong-Staal
Journal:  Microbiol Rev       Date:  1991-06

9.  Tumor necrosis factor-alpha, interleukin 1, and phorbol myristate acetate are independent activators of NF-kappa B which differentially activate T cells.

Authors:  S W Krasnow; L Q Zhang; K Y Leung; L Osborn; S Kunkel; G J Nabel
Journal:  Cytokine       Date:  1991-09       Impact factor: 3.861

10.  Activation of the human immunodeficiency virus type 2 enhancer is dependent on purine box and kappa B regulatory elements.

Authors:  D M Markovitz; M J Smith; J Hilfinger; M C Hannibal; B Petryniak; G J Nabel
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

View more
  20 in total

1.  Correlates of latent and productive HIV type-1 infection in tonsillar CD4(+) T cells.

Authors:  B Rosok; J E Brinchmann; P Voltersvik; J Olofsson; L Bostad; B Asjö
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

2.  The sequence and structure of the 3' arm of the first stem-loop of the human immunodeficiency virus type 2 trans-activation responsive region mediate Tat-2 transactivation.

Authors:  C Browning; J M Hilfinger; S Rainier; V Lin; S Hedderwick; M Smith; D M Markovitz
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Induction of AIDS by simian immunodeficiency virus lacking NF-kappaB and SP1 binding elements.

Authors:  P O Ilyinskii; M A Simon; S C Czajak; A A Lackner; R C Desrosiers
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

4.  Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo.

Authors:  S J Popper; A D Sarr; A Guèye-Ndiaye; S Mboup; M E Essex; P J Kanki
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Enhanced responsiveness to nuclear factor kappa B contributes to the unique phenotype of simian immunodeficiency virus variant SIVsmmPBj14.

Authors:  S C Dollard; S Gummuluru; S Tsang; P N Fultz; S Dewhurst
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  DEK, an autoantigen involved in a chromosomal translocation in acute myelogenous leukemia, binds to the HIV-2 enhancer.

Authors:  G K Fu; G Grosveld; D M Markovitz
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

7.  Human immunodeficiency virus (HIV)-2-specific T lymphocyte proliferative responses in HIV-2-infected and in HIV-2-exposed but uninfected individuals in Guinea-Bissau.

Authors:  S Andersson; O Larsen; Z Da Silva; H Linder; H Norrgren; F Dias; R Thorstensson; P Aaby; G Biberfeld
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

8.  Human immunodeficiency virus type 2 produces a defect in CD3-gamma gene transcripts similar to that observed for human immunodeficiency virus type 1.

Authors:  I Segura; C Delmelle-Wibaut; M Janssens; Y Cleuter; A van den Broeke; R Kettmann; K E Willard-Gallo
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

9.  GLI-2 modulates retroviral gene expression.

Authors:  M J Smith; S D Gitlin; C M Browning; B R Lane; N M Clark; N Shah; S Rainier; D M Markovitz
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

10.  The peri-kappa B site mediates human immunodeficiency virus type 2 enhancer activation in monocytes but not in T cells.

Authors:  N M Clark; M C Hannibal; D M Markovitz
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.